These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 1336152

  • 1. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.
    Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH.
    Neurosci Lett; 1992 Nov 23; 147(1):58-62. PubMed ID: 1336152
    [Abstract] [Full Text] [Related]

  • 2. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
    Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S, Marquardt B, Stabel S.
    Curr Biol; 1994 Dec 01; 4(12):1077-86. PubMed ID: 7704571
    [Abstract] [Full Text] [Related]

  • 3. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
    Zheng-Fischhöfer Q, Biernat J, Mandelkow EM, Illenberger S, Godemann R, Mandelkow E.
    Eur J Biochem; 1998 Mar 15; 252(3):542-52. PubMed ID: 9546672
    [Abstract] [Full Text] [Related]

  • 4. PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3 beta.
    Mulot SF, Hughes K, Woodgett JR, Anderton BH, Hanger DP.
    FEBS Lett; 1994 Aug 08; 349(3):359-64. PubMed ID: 8050597
    [Abstract] [Full Text] [Related]

  • 5. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain.
    Yang SD, Yu JS, Shiah SG, Huang JJ.
    J Neurochem; 1994 Oct 08; 63(4):1416-25. PubMed ID: 7931292
    [Abstract] [Full Text] [Related]

  • 6. Phosphorylation of tau by cyclic-AMP-dependent protein kinase.
    Robertson J, Loviny TL, Goedert M, Jakes R, Murray KJ, Anderton BH, Hanger DP.
    Dementia; 1993 Oct 08; 4(5):256-63. PubMed ID: 8261023
    [Abstract] [Full Text] [Related]

  • 7. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP.
    Acta Neuropathol; 2002 Feb 08; 103(2):91-9. PubMed ID: 11810173
    [Abstract] [Full Text] [Related]

  • 8. Phosphorylation of tau by glycogen synthase kinase-3 beta in vitro produces species with similar electrophoretic and immunogenic properties to PHF-tau from Alzheimer's disease brain.
    Mulot SF, Hughes K, Woodgett JR, Anderton BH, Hanger DP.
    Biochem Soc Trans; 1995 Feb 08; 23(1):45S. PubMed ID: 7758758
    [No Abstract] [Full Text] [Related]

  • 9. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.
    Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M, Ishiguro K, Yamaguchi H.
    Neurosci Res; 1998 Aug 08; 31(4):317-23. PubMed ID: 9809590
    [Abstract] [Full Text] [Related]

  • 10. Protein kinase FA/GSK-3 phosphorylates tau on Ser235-Pro and Ser404-Pro that are abnormally phosphorylated in Alzheimer's disease brain.
    Yang SD, Song JS, Yu JS, Shiah SG.
    J Neurochem; 1993 Nov 08; 61(5):1742-7. PubMed ID: 8228990
    [Abstract] [Full Text] [Related]

  • 11. Microtubule-associated protein tau, paired helical filaments, and phosphorylation.
    Mandelkow EM, Biernat J, Drewes G, Steiner B, Lichtenberg-Kraag B, Wille H, Gustke N, Mandelkow E.
    Ann N Y Acad Sci; 1993 Sep 24; 695():209-16. PubMed ID: 7694533
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ, Grundke-Iqbal I, Iqbal K.
    Eur J Neurosci; 2007 Jan 24; 25(1):59-68. PubMed ID: 17241267
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sites of phosphorylation in tau and factors affecting their regulation.
    Anderton BH, Betts J, Blackstock WP, Brion JP, Chapman S, Connell J, Dayanandan R, Gallo JM, Gibb G, Hanger DP, Hutton M, Kardalinou E, Leroy K, Lovestone S, Mack T, Reynolds CH, Van Slegtenhorst M.
    Biochem Soc Symp; 2001 Jan 24; (67):73-80. PubMed ID: 11447841
    [Abstract] [Full Text] [Related]

  • 16. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5.
    Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E.
    FEBS Lett; 1993 Dec 28; 336(3):417-24. PubMed ID: 8282104
    [Abstract] [Full Text] [Related]

  • 17. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau.
    Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, Vandenheede JR, Mandelkow E.
    FEBS Lett; 1992 Dec 21; 314(3):315-21. PubMed ID: 1334849
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
    Imahori K, Uchida T.
    J Biochem; 1997 Feb 21; 121(2):179-88. PubMed ID: 9089387
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.